Palisaded neutrophilic and granulomatous dermatitis associated with ankylosing spondylitis

التفاصيل البيبلوغرافية
العنوان: Palisaded neutrophilic and granulomatous dermatitis associated with ankylosing spondylitis
المؤلفون: Blanca de Unamuno Bustos, Ana García Rabasco, Rosa Ballester Sánchez, Víctor Alegre de Miquel
المصدر: The American Journal of dermatopathology. 35(8)
سنة النشر: 2013
مصطلحات موضوعية: Adult, Systemic disease, medicine.medical_specialty, Neutrophils, Arthritis, Dermatitis, Dermatology, Antibodies, Monoclonal, Humanized, Receptors, Tumor Necrosis Factor, Pathology and Forensic Medicine, Etanercept, Arthritis, Rheumatoid, medicine, Humans, Spondylitis, Ankylosing, Ankylosing spondylitis, Granuloma, business.industry, Adalimumab, General Medicine, medicine.disease, Rheumatoid arthritis, Antirheumatic Agents, Immunoglobulin G, Female, Sarcoidosis, Granulomatous Dermatitis, business, Systemic vasculitis, medicine.drug
الوصف: Palisaded neutrophilic granulomatous dermatitis (PNGD) is a rare neutrophilic dermatosis that shows a broad clinical and histopathological spectrum. The clinical presentation of PNGD varies from asymptomatic papules, to nodules, to annular plaques. The most common clinical presentation is erythematous papules on the extensor surface of extremities, especially fingers and elbows. Histopathological findings demonstrate a spectrum of changes that reflect the evolution of the lesions, from only sparse mixed perivascular infiltrates to interstitial or palisaded granuloma formation with dermal fibrosis. The cause of PNGD is unknown, but there is a prominent association with systemic conditions, particularly with autoimmune diseases, representing rheumatoid arthritis and systemic lupus erythematosus, the most common associations. It has also been described associated to systemic sclerosis, sarcoidosis, systemic vasculitis, inflammatory bowel disease, and lymphoproliferative disorders, and also drugs have been implicated. Recently, it has been described the potential association with tumor necrosis factor alpha inhibitors. This dermatosis should be considered as a marker of systemic disease and particularly it should be considered in patients with history of autoimmune disorders who present with papular eruptions on the extremities.
تدمد: 1533-0311
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45e5b8687f896bf7b1fd37847c5521dd
https://pubmed.ncbi.nlm.nih.gov/23974221
رقم الانضمام: edsair.doi.dedup.....45e5b8687f896bf7b1fd37847c5521dd
قاعدة البيانات: OpenAIRE